August 16, 2012

Honeywell Announces Phaseout Of Oxyfume Ethylene Oxide Sterilant Blends

New website launched to assist customers with identifying and returning cylinders

MORRIS TOWNSHIP, N.J., Aug. 16, 2012 – Honeywell (NYSE: HON) announced today that it is phasing out its line of Oxyfume® ethylene oxide sterilant blends, primarily used to sterilize hospital and laboratory equipment, by the end of 2013.

The phaseout is in response to U.S. Clean Air Act regulations that will ban the sale and use of most HCFC-based products like Oxyfume in the United States as of Dec. 31, 2014. Current and former Oxyfume customers are encouraged to search their facilities for unused cylinders now and contact Honeywell for cylinder return information. Honeywell will not be able to receive any cylinders after production ceases by the end of 2013.

A new website, www.honeywell-sterilants.com, provides customers and users with critical information they need to plan for the phaseout. The website offers resources that can help customers identify unused Oxyfume cylinders in their facility, as well as information on how to return them.

“The time to act is now and customers who find unused Oxyfume cylinders should contact Honeywell today for cylinder return information,” said Jeff Czarnecki, global business director for Honeywell’s Healthcare and Packaging business. “Even if customers are no longer using Oxyfume for their sterilization needs, they should verify they are no longer in possession of cylinders by checking loading docks and other storage areas.”

Honeywell noted that it can cost more than $1,000 per cylinder to dispose of unused cylinders that are deemed hazardous waste.

Honeywell will be able to receive Oxyfume 2002 and Oxyfume 2000 cylinders for recycling until production ceases by the end of 2013. Oxyfume 12, a CFC-based product that was phased out in 1995, cannot be received by Honeywell. Current and former customers should contact Honeywell for information on how to handle these cylinders.

Oxyfume ethylene oxide sterilant blends have been widely used by hospitals, laboratories and medical device manufacturers for more than 40 years. It is estimated that more than 70 percent of hospitals in the United States have used the product in their sterilization facilities.
Performance Materials and Technologies is a global leader in developing and manufacturing advanced materials and process technologies. These materials and technologies are used by people every day in a wide range of industries and applications, from petroleum refining to environmentally friendlier refrigerants to bullet-resistant vests. Our advanced materials are critical in the manufacture of products ranging from nylon to computer chips to pharmaceutical packaging. Process technologies developed by our UOP business form the foundation for most of the world’s refiners, efficiently producing gasoline, diesel, jet fuel and petrochemicals. UOP is now pioneering technology to produce real fuels from renewable energy sources.

Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com.

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements.

# # #